India, April 1 -- Emcutix Biopharmaceuticals, a wholly owned subsidiary of Mumbai-based Emcure Pharmaceuticals, has announced an exclusive in-licensing agreement with WiQo, an innovative Italian derma-cosmetic and medical device company specialised in scientifically validated products.

The strategic partnership grants Emcutix the rights to import, promote, distribute and sell WiQo's ground- breaking product PRX-PLUS in India. The collaboration is set to redefine the landscape of non-invasive skin treatments in the region.

PRX-PLUS has a unique product feature with its deep-impacting formula that instantly tightens the skin, offering a non-invasive, pain-free alternative to traditional aesthetic treatments for those seeking effective res...